(Q38220272)

31 August 2017

title

Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier (English)

1 reference

31 August 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929655%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Esmée Vendel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929655%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

15 June 2014

1 reference

31 August 2017

published in

NeuroMolecular Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929655%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929655%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929655%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

620-642

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929655%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12017-014-8314-x

8 June 2020

exact match

0 references

cites work

Structure and function of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Astrocyte-endothelial interactions at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CAMs and Rho small GTPases: gatekeepers for leukocyte transendothelial migration. Focus on "VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CB2: a cannabinoid receptor with an identity crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Antibody testing for brain immunohistochemistry: brain immunolabeling for the cannabinoid CB₂ receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

In silico patent searching reveals a new cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Assembly and sealing of tight junctions: possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Assembly of the tight junction: the role of diacylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The blood-brain barrier: an overview: structure, regulation, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Evidence for novel cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid CB2 receptors in human brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Alzheimer's disease; taking the edge off with cannabinoids?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Inhibition of claudin-11 and occludin expression in rat Sertoli cells by mono-(2-ethylhexyl) phthalate through p44/42 mitogen-activated protein kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Low extracellular Ca2+ conditions induce an increase in brain endothelial permeability that involves intercellular Ca2+ waves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Targeting the endocannabinoid system: to enhance or reduce?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Pathobiology of ischaemic stroke: an integrated view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Mini-review: Transendothelial migration of leukocytes: through the front door or around the side of the house?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Structural and Functional Variations in Capillary Systems within the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Interleukin-1beta: a bridge between inflammation and excitotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Biomarkers of oxidative damage and inflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Serine proteases and brain damage - is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Neurons on cannabinoids: dead or alive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Alcohol-induced blood-brain barrier dysfunction is mediated via inositol 1,4,5-triphosphate receptor (IP3R)-gated intracellular calcium release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The blood-brain barrier and glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The blood-brain barrier/neurovascular unit in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cellular signal transduction by anandamide and 2-arachidonoylglycerol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Neuronal death after brain injury. Models, mechanisms, and therapeutic strategies in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid-induced immune suppression and modulation of antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The cannabinoid system and cytokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Tight junctions of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The seek of neuroprotection: introducing cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Presence and regulation of the endocannabinoid system in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Leukocyte extravasation: chemokine transport and presentation by the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CB2 receptor-mediated migration of immune cells: it can go either way

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Anti-inflammatory properties of CB1-receptor antagonist involves beta2 adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CB2 cannabinoid receptors promote mouse neural stem cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Endocannabinoids mediate neuron-astrocyte communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Strategies to advance translational research into brain barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The large apparent work capability of the blood-brain barrier: A study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Modulating the endocannabinoid system in human health and disease--successes and failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Chemically induced oxidative stress disrupts the E-cadherin/catenin cell adhesion complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Blood-brain barrier: structural components and function under physiologic and pathologic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Migraine aura: new information on underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The dual neuroprotective-neurotoxic profile of cannabinoid drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Molecular signaling mechanisms of cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Regulation of MMP-9 by a WIN-binding site in the monocyte-macrophage system independent from cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Immune control by endocannabinoids - new mechanisms of neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Signaling in leukocyte transendothelial migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoid receptors and their role in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoids and gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoids and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CNS immune surveillance and neuroinflammation: endocannabinoids keep control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Activation of the CB2 receptor system reverses amyloid-induced memory deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: Partial involvement of the

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8314-X

p38 MAPK mediates calcium oxalate crystal-induced tight junction disruption in distal renal tubular epithelial cells

21 January 2018

1 reference

12 December 2020

[Reactive oxygen species and inflammation]

1 reference

12 December 2020

Cannabinoid receptor 1 blockade protects human retinal pigment epithelial cells from oxidative injury.

1 reference

12 December 2020

Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.

1 reference

12 December 2020

Therapeutic action of cannabinoids in a murine model of multiple sclerosis.

1 reference

12 December 2020

Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression

1 reference

12 December 2020

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

12 December 2020

Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia.

1 reference

12 December 2020

Pharmacological actions of cannabinoids.

1 reference

12 December 2020

Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis

1 reference

12 December 2020

Neurodegeneration in Striatum Induced by the Mitochondrial Toxin 3-Nitropropionic Acid: Role of Matrix Metalloproteinase-9 in Early Blood-Brain Barrier Disruption?

1 reference

12 December 2020

Neuronal death and blood-brain barrier breakdown after excitotoxic injury are independent processes

1 reference

12 December 2020

Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity

1 reference

12 December 2020

Calcium signals and protein tyrosine kinases are required for the induction of c-jun in Jurkat cells stimulated by the T cell-receptor complex and oxidative signals.

1 reference

12 December 2020

Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity.

1 reference

12 December 2020

The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells

1 reference

12 December 2020

Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions

1 reference

12 December 2020

Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1

1 reference

12 December 2020

Dependence of epithelial intercellular junction biogenesis on thapsigargin-sensitive intracellular calcium stores

1 reference

12 December 2020

Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production.

1 reference

12 December 2020

Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures.

1 reference

12 December 2020

The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt

1 reference

12 December 2020

Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures.

1 reference

12 December 2020

Neuroprotective agents: cannabinoids

1 reference

12 December 2020

Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism.

1 reference

12 December 2020

Regulation of protein kinase enzymatic activity in Jurkat T cells during oxidative stress uncoupled from protein tyrosine kinases: role of oxidative changes in protein kinase activation requirements and generation of second messengers

1 reference

12 December 2020

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

1 reference

12 December 2020

Ultrastructure of the blood-brain barrier in the rabbit.

1 reference

12 December 2020

Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus.

1 reference

12 December 2020

Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells

1 reference

12 December 2020

Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease

1 reference

12 December 2020

Mending the broken brain: neuroimmune interactions in neurogenesis

1 reference

12 December 2020

Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells

1 reference

12 December 2020

Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells

1 reference

12 December 2020

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

1 reference

12 December 2020

Cortical spreading depression activates and upregulates MMP-9.

1 reference

12 December 2020

Concentration-dependent effects of cytochalasin D on tight junctions and actin filaments in MDCK epithelial cells.

1 reference

12 December 2020

Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.

1 reference

12 December 2020

A role for intracellular calcium in tight junction reassembly after ATP depletion-repletion

1 reference

12 December 2020

p38 MAPK regulates cavitation and tight junction function in the mouse blastocyst

1 reference

12 December 2020

Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists

1 reference

12 December 2020

Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells

1 reference

12 December 2020

The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway

1 reference

12 December 2020